Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry+company

MED-EL SYNCHRONY PIN pediatric expanded-indications study

Also known as: MED-EL SYNCHRONY PIN Cochlear Implant, SYNCHRONY PIN, SYNCHRONY +FLEXSOFT, SYNCHRONY +FLEX28, SYNCHRONY +FLEX24, G180269, NCT03900897, NCT04130113

MED-EL Corporation

Primary source

Company

MED-EL Corporation

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Interventional/NA

Status

Completed

Target Gene

—

Route / Mode

Implantable cochlear implant system

Confidence

87%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

United States

Population

pediatric, sensorineural-hearing-loss, expanded-indication, cochlear-implant

Trial IDs

Mechanism

Implantable cochlear implant system evaluated in children 7 months to 5 years 11 months outside then-current FDA-approved candidacy criteria.

Indications

Hearing Loss Sensorineural Hearing Loss

Notes

Normalized from an over-broad generated "Cochlear Implant" record. The verified industry program here is the MED-EL pediatric expanded-indications study, not the separate Antwerp "Hear Again, Work Again" observational study where Cochlear is only listed as a collaborator.

Evidence & Sources

2 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, programType, stage, status, route, populationTags...

IDs: NCT03900897, NCT04130113, G180269

Open

company

Supports: company, modality, mechanism, indications

IDs: MED-EL, cochlear implants

Open

Key Events

2019-06-17